Atlas Trials

A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer

Clinical trial NCT03193528 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03193528
Sponsor
Cedars-Sinai Medical Center
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Bladder Cancer
Start date
2016-12-30
Primary completion
2026-07-01
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.